NGL Fine-ChemNSE:NGLFINE +3.13%78 Interest Coverage is 16.24 as of Mar. 2026, which is 1% below its 10-year median of 16.34. GuruFocus rates NSE:NGLFINE with a GF Score™ of 78/100 and a GF Value™ of ₹2,836.47 (Fairly Valued). The stock has 8 warning signs investors should review. Among 684 Drug Manufacturers companies, NGL Fine-Chem ranks worse than 51.61% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. NGL Fine-Chem's
Operating Income
for the
three
months ended in Mar. 2026 was ₹164 Mil. NGL Fine-Chem's Interest Expense for the
three
months ended in Mar. 2026 was ₹-10 Mil.
NGL Fine-Chem's interest coverage for the quarter that ended in Mar. 2026 was 16.24.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for NGL Fine-Chem's Interest Coverage or its related term are showing as below:
NSE:NGLFINE'
s Interest Coverage Range Over the Past 10 Years
Min: 6.16 Med: 16.34 Max: 41.48
Current: 11.7
NSE:NGLFINE's Interest Coverage is ranked worse than 51.61% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs NSE:NGLFINE: 11.70
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
NGL Fine-Chem Interest Coverage Related Terms
NGL Fine-Chem Interest Coverage Historical Data
* Premium members only.
The historical data trend for NGL Fine-Chem's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:NGLFINE vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NGL Fine-Chem Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Interest Coverage distribution charts can be found below:
* The bar in red indicates where NGL Fine-Chem's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGL Fine-Chem (NSE:NGLFINE) has a Interest Coverage of 16.24 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on NGL Fine-Chem and its competitors. This is near median its historical median of 16.34. Over the past decade, NGL Fine-Chem's Interest Coverage has ranged from 6.16 to 41.48. According to the industry distribution chart, NGL Fine-Chem ranks #353 out of 684 companies in the Drug Manufacturers industry, placing it in the top 51.6%.
Is NGL Fine-Chem's Interest Coverage too high?
NGL Fine-Chem's current Interest Coverage of 16.24 is near median its 10-year median of 16.34. Over the past 10 years, this metric has ranged from a low of 6.16 to a high of 41.48. The Drug Manufacturers industry median Interest Coverage is 12.77. NGL Fine-Chem's value of 16.24 is 27.2% above this industry median. Based on the distribution chart, NGL Fine-Chem ranks #353 out of 684 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, NGL Fine-Chem has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NGL Fine-Chem's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, NGL Fine-Chem ranks #353 out of 684 companies for Interest Coverage. This places NGL Fine-Chem in the lower half of its industry. The industry median Interest Coverage is 12.77. NGL Fine-Chem's value of 16.24 is 27.2% above this benchmark. Historically, NGL Fine-Chem's own Interest Coverage has ranged from 6.16 to 41.48 over the past decade. While the company's 10-year median is 16.34 vs. the industry median of 12.77, NGL Fine-Chem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NGL Fine-Chem's current Interest Coverage of 16.24 is 27.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on NGL Fine-Chem and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NGL Fine-Chem's current Interest Coverage is 16.24, which is near median its own 10-year median of 16.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NGL Fine-Chem stock overvalued right now?
Based on GuruFocus' analysis, NGL Fine-Chem (NSE:NGLFINE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,836.47, compared to a current price of ₹3,083.40 — trading 8.7% above its estimated fair value. The current Interest Coverage is 16.24, which is near median its 10-year median of 16.34 and 27.2% above the Drug Manufacturers industry median of 12.77. NGL Fine-Chem's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For NGL Fine-Chem (NSE:NGLFINE), the current Interest Coverage is 16.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?
Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued.
The current stock price of ₹3,083.40 is trading 8.7% above its estimated GF Value™ of ₹2,836.47.
GuruFocus considers NGL Fine-Chem to be Fairly Valued.
Key valuation signals for NSE:NGLFINE:
Interest Coverage: 16.24 (near median its 10-year median of 16.34)
GF Value™: ₹2,836.47 vs. price of ₹3,083.40 (8.7% above fair value)
Industry Position: 27.2% above the Drug Manufacturers median (#353 of 684)
No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
78GF Score
Get the complete analysis for NSE:NGLFINE
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NGLFINE has been successfully added to your 
